Diamyd Medical AB (publ)
DYMDF
$0.73
$0.000.00%
OTC PK
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.87% | -19.13% | 27.40% | -25.89% | -32.79% |
| Total Depreciation and Amortization | 10.19% | 5.95% | 3.29% | 2.64% | 4.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3,002.75% | 98.02% | -236.58% | 3,539.64% | -94.01% |
| Change in Net Operating Assets | 144.74% | -256.78% | -109.23% | 770.44% | 117.76% |
| Cash from Operations | -0.02% | -11.15% | -43.21% | 19.56% | -0.59% |
| Capital Expenditure | -1,029.90% | 84.03% | -368.16% | 4.12% | 82.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 38.18% | 149.96% | -- |
| Cash from Investing | -932.54% | -101.83% | 27.86% | 147.69% | -1,015.26% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,225.51% | -105.74% | 1,419.33% | -120.27% | 2,078.47% |
| Cash from Financing | 45,518.65% | -101.03% | 7,141.78% | -101.38% | 28,627.72% |
| Foreign Exchange rate Adjustments | 1,159.65% | 130.63% | -227.45% | -20.70% | 353.05% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 588.34% | -217.58% | 489.97% | 26.18% | 65.42% |